Heart Disease clinical trials

Explore recruiting heart disease clinical trials.

Recruiting heart disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, placebo-controlled, parallel-group, investigator- and participant-blinded Phase 2a study to investigate the efficacy, safety, and tolerability of DFV890 and MAS825 for inflammatory marker reduction in an adult population with coronary heart disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Theophylline Effects in the Fontan Circulation

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

The Effect of Albumin Levels on Pharmacokinetics of Cefazolin in Adult Cardiac Surgery: A Prospective, Randomized, Open-label, Parallel-group Pharmacokinetic Study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the Eleveld Pharmacokinetic Model for Propofol and Remifentanil in Cardiac Anesthesia with Cardiopulmonary Bypass

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Regression of Atherosclerosis induced by liFe chAnging Experience with psiLocybin

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Heart Disease trials by city

Heart Disease in Toronto Heart Disease in Vancouver Heart Disease in Montreal Heart Disease in Calgary Heart Disease in Edmonton Heart Disease in Ottawa Heart Disease in Winnipeg Heart Disease in Quebec City Heart Disease in Hamilton Heart Disease in Kitchener Heart Disease in London Heart Disease in Halifax Heart Disease in New York Heart Disease in Los Angeles Heart Disease in Chicago Heart Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease